Latest News
Conference Coverage
Diagnosing OSA: Polysomnography beats Fitbit, apps
The device and applications universally overestimated sleep time and showed only moderate association between sleep efficiency and AHI...
Latest News
Drug-pricing policies find new momentum as ‘a 2020 thing’
Spurred on by midterm election results that showed health care to be a deciding issue, lawmakers are pushing a bevy of new proposals and...
Conference Coverage
SNOT-22 may help identify patients with undiagnosed OSA
CORONADO, CALIF. – Finding underscores the overlap in symptoms between chronic rhinosinusitis and OSA.
Latest News
Trump zeroes in on surprise medical bills in White House chat with patients, experts
President Trump has instructed administration officials to investigate how to prevent surprise medical bills, broadening his focus on drug prices...
FDA/CDC
Device approved to treat PDA in premature infants
The FDA nod is the first for use in very-low-birth infants
From the Journals
Perceptions of liver transplantation for ALD are evolving
Liver transplantation for alcohol-associated liver disease is occurring earlier and more frequently than before.
From the Journals
Renal transplant improves survival in lupus nephritis patients
Transplant conferred a 70% reduction in overall death risk in patients with end-stage renal disease due to lupus nephritis.
From the Journals
TAPs top epidurals in ventral hernia repair
Patients who had transversus abdominis plane blocks for pain control had shorter hospital stays and received fewer opioids, compared with those...
News from the FDA/CDC
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
The FDA is investigating data from a recent meta-analysis of increased long-term mortality risk from paclitaxel-coated balloons and paclitaxel-...
Feature
GoFundMe CEO: ‘Gigantic gaps’ in health system showing up in crowdfunding
Scrolling through GoFundMe reveals seemingly an endless number of people who need help or support. A common theme: the cost of health care.
Latest News
ATTRACT trial shouldn’t detract from pharmacomechanical thrombolysis
CHICAGO –